← Evidence map

ArticleClinical and translational medicine2022

Inhibition of CXXC5 function reverses obesity-related metabolic diseases.

Seol Hwa Seo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35384342